|

- 积分
- 1184
- 威望
- 1184
- 包包
- 1887
|
本帖最后由 细胞海洋 于 2013-1-5 08:35 编辑 9 |# D; g3 Z: X% E. n
$ G7 e: ?& g6 e7 E0 c( L[hide][/hide]& \$ q" }5 t6 x7 |; m8 L
9 \& k" H: a& Z; o/ _
ISSN 1064-3745 e-ISSN 1940-60290 G7 D1 _3 Z2 j# h
ISBN 978-1-61779-611-1 e-ISBN 978-1-61779-612-8
6 l7 k: u* u4 t( p2 U* l8 iDOI 10.1007/978-1-61779-612-81 z5 s# y C: Y8 ^( m; H$ K
Springer New York Dordrecht Heidelberg London
1 `& s2 ^% a" W6 vLibrary of Congress Control Number: 2012931559
& R; e: ~) v C+ e' l; k© Springer Science+Business Media, LLC 20125 U% i! r( V! Y! u
9 P5 W+ Q0 P/ |
Contents" d- y* d. \& U6 o' l
Preface. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ; J6 C+ b" }, L; L( m: l
. . . . . . . . . . . . v
7 m5 G, K# q' K- a+ bContributors. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
; G$ M* u& D& G9 x. . . . . . . . . . xi9 M% ]2 e W/ @- z: h. V0 i
PART I EARLY EPIGENETIC EVENTS IN CANCER- p' ]( E; C, x' \0 N1 g' f+ I
1 Epigenetic Markers of Early Tumor Development . . . . . . . . . . . . . . . . . . . . . .
1 _ e, \3 S6 W1 b; { 3
! j- h6 `. }9 Y; p* B cRamona G. Dumitrescu
$ _% c7 c0 M3 R5 L: w8 G2 Epigenetics of Solid Cancer Stem Cells . . . . . . . . . . . . . . . . . . . . . . . . . . . . - I/ z! p; {% m3 E; l! n
. . 15
! y, }* t' h' l3 s0 m* i4 `Alok Mishra and Mukesh Verma$ s/ C" h' J; t/ |- v2 i
PART II CANCER SPECIFIC TYPE EPIGENETIC CHANGES8 b+ l7 c' b4 h" N
3 DNA Methylation and Histone Modifications in Breast Cancer . . . . . . . . . . . . 35# C" T* B' g b2 @( h
Ramona G. Dumitrescu
2 ?5 x7 Z2 a( S: H& `: h* T8 m4 DNA Methylation Changes in Prostate Cancer . . . . . . . . . . . . . . . . . . . . . . . .
Y0 _: O+ x& T; I$ u. |470 @( h7 H6 q" C9 K7 d% Q
Wolfgang Goering, Michael Kloth, and Wolfgang A. Schulz
9 P1 ^7 @+ B: c* `; \! `2 ]5 DNA Methylation in Promoter Region as Biomarkers
" \5 V) r+ z* E. m3 c) ]in Prostate Cancer. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . * @) K# x- f; R8 S& H
. . . . . 67
* H+ ~3 `. T4 a9 UMihi Yang and Jong Y. Park$ n( s& x1 d/ ?
6 Epigenetics of Bladder Cancer. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ) U# U! }" r% }2 E
. . . . 111
$ f% n% t1 r* |6 Z( m0 G" tWun-Jae Kim and Yong-June Kim" b) {: S( T% q/ N/ R" c
7 Epigenetics in Myeloid Malignancies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
; z0 H1 m) e7 \6 K6 @2 d% M2 N- L. . 1195 v2 ~% U: i! ^8 ?( Q8 ~
Stefan Deneberg2 C0 a# C: @$ t% L. K
8 The Epigenetics of Brain Tumors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
* v) M& L, b, Q2 c0 w. . 139% }+ F+ K# j: I2 U! B" Y
Adrian M. Dubuc, Stephen Mack, Alexander Unterberger, Paul A. Northcott, and Michael D. Taylor* g& K2 k9 o. D* [( h s
9 DNA Methylation Changes in Cervical Cancers . . . . . . . . . . . . . . . . . . . . . . . 155
`$ r# K$ x7 H$ A3 Y( EQiang Lu, Dehua Ma, and Shuping Zhao
3 N# {6 [" l8 k8 t4 c- s" ?10 Epigenetics of Colon Cancer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
, ^5 b s& K5 A( F, a$ f. . . . . 177# |# g2 N5 ^2 ?/ e l4 ?! j8 M
Sharad Khare and Mukesh Verma
* r) N3 j+ \' e. m: G7 B11 Promoter Methylation in Head and Neck Tumorigenesis. . . . . . . . . . . . . . . . . 187( f6 z% M4 _, O3 Z l+ S( N, l
Josena K. Stephen, Kang Mei Chen, Shaleta Havard, Glynis Harris, and Maria J. Worsham
; @8 [* Z9 f/ p6 ^! k8 R; }12 Epigenome and DNA Methylation in Oral. c. F. P" Y' k ^# F+ L
Squamous Cell Carcinoma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
% G9 [5 s% ^ Y3 v) S. 207
0 a5 H) u% \, H6 I, z: EMario Pérez-Sayáns García and Abel García-García6 _0 Q7 K7 n a& B. {
Mario Pérez-Sayáns García and Abel García-García$ Z+ A8 l/ g' M1 I0 P+ h
9 }0 m1 {, \3 o3 D
+ I0 ?; H" \- h! Fviii Contents7 e: j: \! r: D
13 Clinical Implications of Epigenetic Alterations in Human8 h1 f" N7 [! D. _) P
Thoracic Malignancies: Epigenetic Alterations in Lung Cancer . . . . . . . . . . . . 2211 s6 M9 e0 H# t; u
Keiko Shinjo and Yutaka Kondo8 Z0 W4 q; u3 {7 _
14 The Role of MicroRNAs in the Management of Liver Cancer . . . . . . . . . . . . . 241) G, s s) B- V8 G6 ?
Krishna K. Banaudha and Mukesh Verma
( M! d5 `4 E, W15 Epigenetics in Ovarian Cancer. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4 q/ j: u2 q5 F& L5 F
. . . . 2538 ^) t: w8 t8 C, U" j. J( O- d
L.M.S. Seeber and P.J. van Diest! I1 R- X, q7 Z# }
5 ?2 L2 E( o+ ^0 g" F8 K
PART III METHODS AND TECHNOLOGIES USED FOR EPIGENETIC CHANGES’ DETECTION: i* Y. s: @! e9 r0 }* I, ?. O2 u8 f
- ~4 A! T: A4 |" O% c1 ~9 U
16 DNA Methylation in Pancreatic Cancer: Protocols
! D; T+ R( A- |- S: g9 S- n% jfor the Isolation of DNA and Bisulfite Modification . . . . . . . . . . . . . . . . . . . . 273& h" X' S" n! {& \9 X
Katja Biewusch, Marie Heyne, Robert Grützmann, and Christian Pilarsky
5 Z9 o' s" Z, l0 L+ b9 a17 Detection and Analysis of DNA Methylation by Pyrosequencing . . . . . . . . . . . 281
3 V' w4 ?2 [' O+ L+ wHilary A.A. Colyer, Richard N. Armstrong, Daniel J. Sharpe, and Ken I. Mills) w& Y' @* D4 Z( n0 N* `' R. i
18 Screening for miRNA Expression Changes Using Quantitative$ {! ^, C' l$ V4 Y+ |3 z
PCR (Q-PCR) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . + J9 i1 J( h4 ?/ N6 l8 I/ L) C: ]7 L% _
. . . . 293
' i% v* y/ ]) Z- y o9 W* }0 kRichard N. Armstrong, Hilary A.A. Colyer, and Ken I. Mills2 g1 ?- O+ Z: q
19 Genome-Wide Methylation Analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 V5 i" B1 i2 w& W" O1 m6 @
. 303
Z f6 G8 r! G3 }Alexander Unterberger, Adrian M. Dubuc, and Michael D. Taylor! t4 h/ {; e9 T- t7 g0 p% t
20 Microarray for Epigenetic Changes: Gene Expression Arrays . . . . . . . . . . . . . . 319 s3 m5 \+ i& `" }5 b8 _0 k
Hilary A.A. Colyer, Richard N. Armstrong, and Ken I. Mills" L( R9 B. q G
21 Detecting DNA Methylation Using the Methylated CpG A: m# @% ]9 N" o
Island Amplification and Microarray Technique. . . . . . . . . . . . . . . . . . . . . . . .
* a0 F0 W: A& T0 T) f- m _329* e n- ?5 j" z( x9 N6 s. h
Hilary A.A. Colyer, Margaret Dellett, and Ken I. Mills
7 @$ q' f6 V" r& E. {" ]" B _( j; W% Y% p9 d
PART IV FACTORS THAT INFLUENCE THE EPIGENETIC CHANGES IN CANCER! K- a, l& J4 v, {
, b5 @( c% W6 A6 x0 K( ` y
22 Nutrigenomics: Implications for Breast and Colon Cancer Prevention . . . . . . . 343$ x$ S ]* ^( f4 I% W. k3 m
Gabriela Riscuta and Ramona G. Dumitrescu' `1 D# C6 R5 P8 G- H
23 Dietary and Lifestyle Factors of DNA Methylation . . . . . . . . . . . . . . . . . . . . .
|: {& j: X7 m( R359
% ]8 G6 P7 ~ M; \0 q# dUnhee Lim and Min-Ae Song
$ f8 W/ f: ~/ L24 Diet, Epigenetics, and Cancer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
* n, g L+ ^. a8 P7 n" w# Z9 U6 U! c. . . . . 3777 W' w7 g- O: n7 I G+ j9 b1 w
L. Joseph Su
( }- K8 |: [" v# e25 Role of Epigenetics in Cancer Health Disparities . . . . . . . . . . . . . . . . . . . . . . . / ?. a, S2 ~# S5 P# O
395
; l! F% S5 t, DSulma I. Mohammed, Sanya Springfield, and Rina Das
0 Z1 O: D3 H1 ]) @6 S& [; a) a7 p26 Multifactorial Etiology of Gastric Cancer. . . . . . . . . . . . . . . . . . . . . . . . . . .
5 B v+ j9 m' }6 Q* W. . 411
A9 k2 i% u) {+ [Jovanny Zabaleta! T- v/ _# k; T, `
" J$ t9 a% L% k' ] H7 h2 UContents ix
. R8 n! S6 |; @( r
- F0 _! Q: E# v* ~( q2 d
3 s: A1 w6 v+ j' \: D6 nPART V EPIGENETIC EPIDEMIOLOGY2 C' ^1 J0 p5 q1 M$ R$ ?( J
; r9 s4 f# N e27 Epigenetic Epidemiology for Cancer Risk: Harnessing Germline
( W1 w P8 z) @0 ^. ^7 A* l2 REpigenetic Variation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
: d0 A! o# X( t. . . . . 439; S+ L$ J0 }( ^4 K
Kevin Brennan and James M. Flanagan- y' E5 B+ z+ F" A. T" d% X
28 Epigenetic Biomarkers in Cancer Epidemiology. . . . . . . . . . . . . . . . . . . . . . . . 6 O) d7 g, q6 f- l t) I9 T
467! s @4 { ?) a% x8 e! j+ D; A
Mukesh Verma
! [$ s; P6 c k! i4 ~) }6 LIndex . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
: Q- F5 \) p4 `9 W4 v+ i+ n7 V. . . . . . . . . . . . 481$ H- S/ l& E' J2 f Z3 g$ t/ C" ^
|
附件: 你需要登录才可以下载或查看附件。没有帐号?注册
-
总评分: 威望 + 20
包包 + 30
查看全部评分
|